BN Business News
Add your company to Business Communicator →

Prawo i regulacje · 11/01/2022

Nexus Pharmaceuticals, Inc. Seeks Registration as Controlled Substance Importer

Nexus Pharmaceuticals, Inc. has submitted an application to the U.S. government to be registered as an importer of controlled substances, including specific classes of drugs. The company is seeking to import these substances for distribution and sale in the United States.

Source: Federal Register — Justice DepartmentOpen original release →